advertisement
11.4 Prostaglandins (61)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Wang Y
Clinics 2020; 75: e1874
91604 OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy
Weindler H
BMC Ophthalmology 2020; 20: 444
91324 Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male Guinea pigs following repeated exposure
Ali AF
Folia morphologica 2022; 81: 52-64
91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Ruangvaravate N
Clinical Ophthalmology 2020; 14: 3109-3119
91731 Comparison between Latanoprost, Travoprost, and Tafluprost in reducing intraocular pressure fluctuations in patients with glaucoma
Faseeh AE
European Journal of Ophthalmology 2021; 0: 1120672121990540
91738 Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
Nakakura S
BMJ open 2021; 11: e040301
91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Rubião F
Current Drug Delivery 2020; 0:
91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Su CC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251
91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Harasymowycz P
British Journal of Ophthalmology 2022; 106: 640-647
90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Medeiros FA
Ophthalmology 2020; 127: 1627-1641
91725 Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
Halder A
Clinical Ophthalmology 2020; 14: 3057-3064
91811 The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST
Wu N
BMC Ophthalmology 2020; 20: 422
91604 OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy
Spitzer MS
BMC Ophthalmology 2020; 20: 444
91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Choojun K
Clinical Ophthalmology 2020; 14: 3109-3119
91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Royer C
British Journal of Ophthalmology 2022; 106: 640-647
91725 Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
Khopade AJ
Clinical Ophthalmology 2020; 14: 3057-3064
91811 The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST
Chen Y
BMC Ophthalmology 2020; 20: 422
90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Walters TR
Ophthalmology 2020; 127: 1627-1641
91738 Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
Kanamori A
BMJ open 2021; 11: e040301
91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Araújo ACF
Current Drug Delivery 2020; 0:
91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Liao Y
Clinics 2020; 75: e1874
91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Lee YC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251
91324 Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male Guinea pigs following repeated exposure
Salama RM
Folia morphologica 2022; 81: 52-64
91731 Comparison between Latanoprost, Travoprost, and Tafluprost in reducing intraocular pressure fluctuations in patients with glaucoma
Allam RS; Shalash AB
European Journal of Ophthalmology 2021; 0: 1120672121990540
91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Srikulsasitorn B
Clinical Ophthalmology 2020; 14: 3109-3119
